India signs an agreement to buy 300,000 doses of Remdesivir from Eva Pharma
India has signed an agreement with Egypt’s Eva Pharma company for drugs and medical supplies to buy 300,000 doses…
Browsing Tag
Remdesivir
Egypt’s Eva Pharma to export 1st batch of coronavirus treatment Favipiravir
Egyptian drug-maker, Eva Pharma, is ready to start exporting “Favipiravir” an anti-viral compound that has proven…
EU signs a deal with Gilead to provide COVID-19 medicine remdesivir
The European Union’s executive said it has signed a contract with Gilead for its COVID-19 medicine remdesivir that…
Eva Pharma doubles antibiotics, blood clotting drugs production to help in treating…
Egypt-based Eva Pharma, manufacturing and sale of remdesivir, said that the company has doubled the production…
Egypt developing four WHO-registered vaccines to treat coronavirus patients
Egypt is developing four vaccines that have been registered by the World Health Organisation (WHO) to treat…
COVID-19 potential drug remdesivir priced at $2,340 for a patient in US
Gilead Sciences Inc priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed…
Gilead says to start testing remdesivir in children
Gilead Sciences Inc, which makes the antiviral drug remdesivir and is now testing it for potential coronavirus…
Egypt’s drug maker, Eva Pharma to manufacture Gilead’s remdesivir for…
Egypt-based Eva Pharma has signed a deal with Gilead Sciences for manufacturing and sale of remdesivir, which has…
Gilead’s Remdesivir study on monkeys shows drug reduced lung damage linked to coronavirus
Gilead Sciences’ antiviral drug remdesivir has helped to prevent macaques infected with the coronavirus from…
AstraZeneca is approaching Gilead about a potential merger – the healthcare deal on record
UK drugmaker AstraZeneca has approached Gilead about a potential merger, a healthcare deal that is expected to be…
Egypt to take part in coronavirus clinical trial testing Gilead’s remdesivir
Egypt will take part in the clinical trial testing for remdesivir as a potential treatment for the coronavirus,…
Remdesivir helped moderate coronavirus patients improve: Gilead
Gilead Sciences Inc said that its antiviral drug remdesivir showed improvement in patients with moderate COVID-19…
Gilead licences drugmakers to make remdesivir coronavirus treatment in 127 countries
Gilead Sciences has signed a licencing agreement with five generic drugmakers to make antiviral drug remdesivir in…
WHO to talk with U.S., Gilead to make coronavirus potential drug remdesivir more widely…
The World Health Organisation (WHO) is planning to speak with the U.S. government and biotech firm Gilead Sciences …
U.S. FDA grants emergency use for remdesivir for very sick coronavirus patients
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Gilead Sciences’…
Gilead says remdesivir coronavirus treatment will need a ‘sustainable model’ to keep it…
Gilead Sciences is doing its best to make experimental antiviral drug remdesivir accessible and affordable to…
Gilead to produce ‘several million’ rounds of remdesivir to help treat coronavirus…
Gilead Sciences said on Thursday that it can produce “several million” rounds of its antiviral drug remdesivir in…
WHO says too early to comment on remdesivir coronavirus trials
It is too early to comment on the remdesivir “positive data” trial results released earlier on Wednesday, said Dr.…
U.S. FDA in ‘ongoing’ talks Gilead to make remdesivir available to coronavirus patients…
The U.S. Food and Drug Administration (FDA) said on Wednesday it has been in “sustained and ongoing” talks with…
Trump urges FDA to approve remdesivir ‘as quickly as they can’
U.S. President Donald Trump said on Wednesday he wants the Food and Drug Administration to approve “as quickly as…
Gilead sees ‘positive data’ on remdesivir coronavirus drug trial
US Gilead Sciences it is aware of “positive data” from one of its studies looking at antiviral drug remdesivir as a…
Japan says to approve Gilead’s remdesivir to treat coronavirus patients
Japan announced on Tuesday that it would approve remdesivir, a antiviral drug made by U.S. firm Gilead Sciences,…
New data on Gilead’s remdesivir – released by accident – shows it flops in first…
Remdesivir developed by Gilead Sciences, a potential antiviral drug to treat coronavirus, has failed in its first…
Gilead drug shows ‘rapid’ recovery in coronavirus cases, yet it is too early to celebrate
University of Chicago Medicine researchers said they saw “rapid recoveries” in 125 patients with coronavirus taking…
Investors must be cautious with Gilead’s potential coronavirus drug Remdesivir, analysts…
As a new report by STAT News showed Gilead’s experimental drug Remdesivir as a promising update on the drug’s…
Avigan, Japan’s wonder drug, and the race for coronavirus treatment
To date, there is no approved drug for coronavirus disease, yet the Japanese anti-flu Avigan – produced in 2014 –…
Ebola “no longer incurable” as Congo trial finds drugs 90% survival rates
Scientists are a step closer to being able to cure the deadly Ebola haemorrhagic fever as two experimental drugs…